Maghemite/poly(d,l-lactide-co-glycolyde) composite nanoplatform for therapeutic applications

A reproducible methodology is described for the synthesis, by following the double emulsion/solvent evaporation technique, of magnetic nanocomposites (average diameter ≈ 135 nm) consisting of maghemite nuclei and a biodegradable poly(d,l-lactide-co-glycolide) matrix. The heterogeneous structure of the nanoparticles can confer them the responsiveness to magnetic gradients, giving both the possibility of their use as a drug delivery system and adequate heating characteristics for a hyperthermia effect. The physical chemistry of the nanocomposites was extensively characterized, this establishing that their surface properties were similar to that of pure poly(d,l-lactide-co-glycolide). From an electrokinetic point of view, zeta potential determinations (as a function of the ionic strength, and pH) pointed out that the nanocomposites were almost indistinguishable from the copolymer. The surface thermodynamic analysis agreed with the electrophoretic one in suggesting that the coverage of the magnetic nuclei was complete, since the hydrophilic nature of maghemite was modified and the nanoparticles turned into hydrophobic, just like the copolymer, when they were embedded into poly(d,l-lactide-co-glycolide). The magnetic behaviours of the composite nanoparticles were also checked. Their heating properties were studied in vitro in a high-frequency alternating gradient of magnetic field: a stable maximum temperature of 47 °C was satisfactorily achieved within 45 min. Blood compatibility of the nanocomposites was also defined in vitro. To our knowledge, this is the first time that such kind of magnetic-sensitive nanoformulation with very promising characteristics (e.g. blood compatibility, magnetic drug targeting capabilities, and hyperthermia) has been developed for therapeutic purposes.